Bottom line
Is MADAX a good fund? The bottom line
MADAX is the Dividend Income Fund Class A share class of Madison Dividend Income Fund, a managed core / intermediate bond mutual fund from Madison.
Annual fees run 1.16% — about $116 a year on every $10,000 invested, more expensive than 78% of core / intermediate bond funds we track.
It returned +1.7% over one year, +5.1% a year over five years (as of Dec 31, 2025, per its prospectus).
With $90.7 million in net assets and 38 holdings, its largest position is Johnson & Johnson (5.3%) and the top 10 make up 39.2% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 83% of category peers
What to watch
- Expensive for its category (1.16%)
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MADAX invests in
"The Madison Dividend Income Fund (the ""Fund"") seeks to produce current income while providing an opportunity for capital appreciation."
"The Fund seeks to achieve its investment objective by investing in equity securities of companies with a market capitalization of over $1 billion and a history of paying dividends, with the ability to increase dividends over time. Under normal market conditions, at least 80% of the Funds net assets (including borrowings for investment purposes) will be invested in dividend paying equity securities. The Fund's investment adviser, Madison Asset Management, LLC (""Madison""), will identify investment opportunities by screening for companies that generally have the following characteristics: (i) a dividend yield of at least 100% of the market dividend yield (for this purpose, the market is the S&P 500); (ii) a strong balance sheet; (iii) a dividend that has been maintained and which is likely to increase; (iv) trade on the high side of the companys historical relative dividend yield, due…
From the fund's prospectus (filed Feb 27, 2026).
MADAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MADAX | +1.7% | +5.1% | — |
| Core / Intermediate Bond median | +7.2% | +1.4% | +3.0% |
Source: Fund prospectus, as of Dec 31, 2025
What MADAX costs
On a $10,000 investment, MADAX's 1.16% expense ratio costs about $116 a year. The prospectus estimates $1,903 in total costs over 10 years (assuming 5% annual returns). The median core / intermediate bond fund charges 0.71%.
MADAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Johnson & Johnson | 5.28% |
| 2 | ExxonMobil Holdings Corp | 4.80% |
| 3 | Chevron Corp | 4.72% |
| 4 | NextEra Energy Inc | 3.80% |
| 5 | CME Group Inc | 3.55% |
| 6 | Procter & Gamble Co/The | 3.53% |
| 7 | Union Pacific Corp | 3.51% |
| 8 | AbbVie Inc | 3.49% |
| 9 | Automatic Data Processing Inc | 3.37% |
| 10 | EOG Resources Inc | 3.14% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 39.2% of the fund. See all top 25 holdings and asset mix →